已收录 272983 条政策
 政策提纲
  • 暂无提纲
Temporary circulatory support for cardiogenic shock
[摘要] Cardiogenic shock can occur due to acute ischaemic or non-ischaemic cardiac events, or from progression of long-standing underlying heart disease. When addressing the cause of underlying disease, the management of cardiogenic shock consists of vasopressors and inotropes; however, these agents can increase myocardial oxygen consumption, impair tissue perfusion, and are frequently ineffective. An alternative approach is to temporarily augment cardiac output using mechanical devices. The use of these devices-known as temporary circulatory support systems-has increased substantially in recent years, despite being expensive, resource intensive, associated with major complications, and lacking high-quality evidence to support their use. This Review summarises the physiological basis underlying the use of temporary circulatory support for cardiogenic shock, reviews the evidence informing indications and contraindications, addresses ethical considerations, and highlights the need for further research.
[发布日期]  [发布机构] 
[效力级别]  [学科分类] 
[关键词] EXTRACORPOREAL MEMBRANE-OXYGENATION;ACUTE MYOCARDIAL-INFARCTION;PERCUTANEOUS CORONARY INTERVENTION;VENTRICULAR ASSIST DEVICE;INTRAAORTIC BALLOON PUMP;HOSPITAL CARDIAC-ARREST;ST-SEGMENT ELEVATION;RANDOMIZED CLINICAL-TRIAL;LIFE-SUPPORT;CARDIOPULMONARY-RESUSCITATION [时效性] 
   浏览次数:4      统一登录查看全文      激活码登录查看全文